The high-profile PUMA footwear lawsuits do not prove that everyday runners face a known increase in injury risk. Their legal significance is narrower: athletes allege that specific shoe designs caused injuries, but courts have not decided those claims. Runners should treat the cases as a reason to monitor pain and evaluate footwear—not as a verdict against PUMA or carbon-plated shoes generally. Individual shoe design, fit, training load, recovery, and nutrition still matter.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What do the lawsuits allege?
- Do the cases establish a risk for recreational runners?
- What does the footwear evidence show?
- Is FDA approval relevant?
- What should a runner do now?
What do the lawsuits allege?
Abby Steiner filed suit against PUMA and Mercedes-Benz Grand Prix in Middlesex Superior Court on April 24, 2026. She alleges that PUMA footwear caused career-ending foot injuries. The filing and later case activity can be checked through the Massachusetts Trial Court public case search. Two similar athlete suits followed on June 9.
Reports identify the Deviate NITRO Elite 2 and 3 and the evoSPEED Tokyo Nitro among the products discussed. The allegations focus on carbon plates and foam that purportedly changed running mechanics and increased injury risk. A carbon-plated shoe contains a stiff carbon-fiber plate within its sole. PUMA describes the Deviate NITRO Elite 2 as using a carbon-fiber PWRPLATE with supercritical NITRO Elite foam. PUMA strongly denies that its performance products caused the alleged injuries; that response is a defense position, not a safety determination.
Do the cases establish a risk for recreational runners?
No. The claims concern elite sprinters using particular PUMA shoes or spikes under their own training conditions. As Front Office Sports reported about the June lawsuits, they do not establish injuries among everyday runners, all PUMA customers, or all users of carbon-plated footwear.
A claim involving one model also cannot automatically be transferred to another model. Plate construction, training volume, running surface, fit, and the runner's body can differ. A sprint spike and a distance-running shoe should not be treated as interchangeable simply because both contain carbon.
What does the footwear evidence show?
The strongest current synthesis does not identify a consistent biomechanical warning across carbon-plated shoes. A 2026 systematic review and meta-analysis of 15 studies found no consistent differences in joint power or leg stiffness between carbon-plated and non-plated footwear. that finding does not prove zero injury risk. The studies examined biomechanics, and the certainty of evidence ranged from low to moderate.
A neutral average can also conceal differences between shoe designs or individual runners. A 2023 systematic review likewise found insufficient high-quality evidence to determine whether footwear prevents bone-stress injuries. A separate computational study found that changing a carbon plate's thickness or location could raise or lower stress in the metatarsals, the long bones of the forefoot. Shoe mechanics are design-specific, not destiny.
Is FDA approval relevant?
No. These are consumer performance shoes, not PUMA products marketed with a medical indication.
Describing them as "FDA-approved" would therefore be inaccurate. The FDA's medical-device framework bases approval or clearance requirements on a product's intended use and classification. The absence of FDA approval for an ordinary running shoe is neither evidence of danger nor proof of safety.
What should a runner do now?
Do not replace symptom-based decisions with headlines about litigation. New or focal pain in the foot or lower leg deserves attention because continued loading can allow a bone-stress injury to progress, according to AAOS OrthoInfo guidance.
- Reduce or stop the activity that produces pain.
- Arrange a clinical evaluation rather than trying to run through focal pain.
- Review recent changes in training, surfaces, recovery, nutrition, shoe fit, and shoe wear.
- If you suspect a product-related injury, retain the shoes, packaging, purchase information, training records, and medical documentation.
- Ask a licensed attorney to assess your individual circumstances before drawing legal conclusions from another athlete's case.
